Search Results

Displaying Results 1-1 of 1 "'SLRX'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.

Nov 11, 2025, 09:18 ET Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering

HOUSTON, Nov. 11, 2025 /PRNewswire/ -- Salarius Pharmaceuticals, Inc. ("Salarius" or the "Company") (NASDAQ: SLRX) today announced the pricing of an underwritten public offering for gross proceeds of approximately $7 million before deducting underwriting discounts

More news about: Salarius Pharmaceuticals, Inc.

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.